recharge your mind™
Niraxx, A NeuroTech Innovation Company
recharge your mind™
Niraxx, A NeuroTech Innovation Company
Recharge your mind™
Empowering individuals to take charge of their brain health for life.
A NeuroTech Innovation Company
We aim to transform brain health care by giving individuals access to effective, non-medication, self-care solutions that are truly wearable.
Niraxx was founded in Nov. 2016 BY Co-founders JOSHUA Chen and Dr. Paolo cassano.
We aim to create a new category of wearables for brain health and related disorders. We believe brain health care has lagged behind due to a focus on brain diseases rather than brain health, and it’s time to evolve beyond the one-size-fits-all approach addressing brain health. There is a huge opportunity to offer effective, evidence-based, non-medication self-care solutions.
Niraxx Launched its first product and app in 2020.
We have spent the last three years working to translate brain photobiomodulation (tPBM), the latest neuromodulation and neurostimulation technology, from bulky devices used in labs and hospitals to comfortable, textile wearables suitable for everyday use. Together, our device and app enable individuals to take control of their brain health effortlessly at their fingertips through six tailored programs of neuromodulating light.
future: AI-based, personalized predictive systems.
We have only just started our work. We continue to work with top researchers and data scientists to improve our algorithms to build a more personalized experience and more efficient delivery of light in calculated dosage (frequency, intensity, duration). We envision a tailored solution that will provide brain state monitoring, live feedback reporting and light dosage adjustment.
CO-FOUNDER & CEO
With 20+ years of entrepreneurial experience, with a focus on light therapy, Joshua is the founder and chairman of two companies. In 2001, he founded his other company, Nature Bright Co., which makes and distributes light therapy products. Joshua has been nominated “Innovator of the Year” by the Orange County Business Journal for two consecutive years.
Paolo Cassano, MD, PhD
CO-FOUNDER & CHAIR OF SCIENTIFIC ADVISORY BOARD
Dr. Cassano is Assistant Professor of Psychiatry at Harvard Medical School, and Director of Photobiomodulaiton at the Massachusetts General Hospital (MGH) Division of Neuropsychiatry and MGH Depression and Clinical Research Program. Dr. Cassano has over 10 years of experience in treatment of neuropsychiatric and mood and anxiety disorders with low level laser therapy and brain bioenergetics.
CHIEF COMMERCIAL OFFICER
Meg is a leader in the field of wearable technology for fitness and health. She was instrumental in commercializing the first wearable sensor garments while at Textronics, a startup later acquired by Adidas where she spent 10 years as Sr. Marketing Director, Commercial Development for digital products. Meg holds five patents in the area of connected wearable for sports and fitness.
Jacek Dmochowski, PhD
Chief Technology Officer
Director, CONTENT & PR
Sherry is an experienced health and science writer skilled at translating complex information into content that are clear, concise and engaging to target audience. She is expert at brand development, content creation and storytelling. Sherry was most recently Editor of Health Care & Startups at Orange County Business Journal.
Roberto has deep experience in the field of fashion, working for his family’s namesake top luxury apparel brand that started back in 1965. He is passionate about the intersectionality of technology and fashion design. His background is in fashion marketing and communications.
Vanessa has a bachelor’s degree in Biological Sciences and is pursuing post- baccalaureate certification in clinical sciences. She is skilled at data collection and analysis.
DIGITAL HEALTH ADVISOR
Beth is a serial entrepreneur, technology professional, and business strategist who has spent the last several years focused on digital medicine. She has 20+ years of technology executive experience, and is currently CEO of Signal 2 Health, a digital medicine product and strategy firm.
Dean STATHAKIS, PHD, JD
Dean has substantial experience in patent procurement, portfolio development, and life cycle management of intellectual property for clients in the biotechnology, pharmaceutical, life sciences, and high technology industries. His expertise include capital raising, new business/product launch and intellectual property licensing.
Michael DRUES, PhD
Michael is President of Vascular Sciences, an education, training, & consulting company offering a broad range of services to medical device, pharmaceutical & biotechnology companies ranging from startups to Fortune 100 companies.
Scientific Advisory Board
Alvaro Pascual-Leone, MD, PHD
Dr. Pascual-Leone is Professor of Neurology at Harvard Medical School and Director of the Berenson-Allen Center at Beth Israel Deaconess Medical Center. His research aims at understanding the mechanisms that control brain plasticity across the life to prevent age-related cognitive decline, reduce the risk for dementia, and minimize the impact of neurodevelopmental disorders
Maurizio Fava, MD
Dr. Fava founded and was Director of Massachusetts General Hospital’s (MGH) Depression Clinical and Research Program (DCRP), one of the most highly regarded depression programs in the U.S. He is a world leader in the field of depression and has authored and co-authored more than 800 original articles published in medical journals with international circulation.
Michael Hamblin, Phd
Dr. Hamblin is a Principal Investigator at MGH’s Wellman Center for Photomedicine, the world’s largest academic research facility dedicated to investigating the effects of light on human biology and to the development of photothearpy for multiple diseases. Dr. Hamblin is a world leader in the field of photomedicine and has published over over 289 peer-reviewed articles.
Justin T. Baker, MD, PHD
Dr. Baker is Scientific Director of the Institute for Technology in Psychiatry (ITP) and Director of Functional Neuroimaging and Bioinformatics at McLean Hospital. He oversees the development of computational phenotyping to improve mental health care. He is also Assistant Professor of Psychiatry at Harvard Medical School.
Maria A. Franceschini, PHD
Dr. Franceschini is Associate Professor in Radiology at Harvard Medical School. She is a pioneer in the field of near-infrared spectroscopy (NIRS), which uses near-infrared light to quantify changes in hemoglobin concentration. Her research focuses on developing NIRS for the
neurosciences, neurology, and brain health.
Andre, R. Brunoni, Md, Phd
Dr. Brunoni is Director of two clinical and research centers at the University of Sao Paulo. His research focuses
His research focuses on the use of non-invasive brain stimulation techniques to treat multiple brain diseases.